Tylenol Sinus Severe
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
67414-507 -
Package NDC
67414-507-00 -
Package NDC
67414-507-04 -
Application number
M012 -
SPL ID
09759b68-4bd0-c41f-e063-6294a90a62a4 -
SPL set ID
6c90b415-4c5f-49e5-beb6-4cf225797b21 -
UNII
362O9ITL9D -
UNII
495W7451VQ -
UNII
04JA59TNSJ -
RxCUI
1243679
What the source publishes
- Labeler
- Jones Healthcare Group - Packaging Services, Inc
- Active ingredients
- ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE
- Form
- TABLET, COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- OTC MONOGRAPH DRUG
- Product type
- HUMAN OTC DRUG
- Prescription
- Non-prescription
Names this record is found by
- Tylenol Sinus Severe
- ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE
- ACETAMINOPHEN
- GUAIFENESIN
- PHENYLEPHRINE HYDROCHLORIDE
Complete source data
{
"name": "Tylenol Sinus Severe",
"splId": "09759b68-4bd0-c41f-e063-6294a90a62a4",
"labels": [
{
"setId": "6c90b415-4c5f-49e5-beb6-4cf225797b21",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6c90b415-4c5f-49e5-beb6-4cf225797b21",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6c90b415-4c5f-49e5-beb6-4cf225797b21"
}
],
"routes": [
"ORAL"
],
"labeler": "Jones Healthcare Group - Packaging Services, Inc",
"finished": true,
"packaging": [
{
"sample": false,
"description": "2500 POUCH in 1 BOX (67414-507-00) / 2 TABLET, COATED in 1 POUCH",
"package_ndc": "67414-507-00",
"identifierStatus": "well-formed",
"marketing_start_date": "20180125"
},
{
"sample": false,
"description": "50 POUCH in 1 CARTON (67414-507-04) / 2 TABLET, COATED in 1 POUCH",
"package_ndc": "67414-507-04",
"identifierStatus": "well-formed",
"marketing_start_date": "20180125"
}
],
"productId": "67414-507_09759b68-4bd0-c41f-e063-6294a90a62a4",
"useDomain": "unknown",
"dosageForm": "TABLET, COATED",
"productNdc": "67414-507",
"deaSchedule": null,
"genericName": "ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE",
"productType": "HUMAN OTC DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ACETAMINOPHEN",
"strength": "325 mg/1"
},
{
"name": "GUAIFENESIN",
"strength": "200 mg/1"
},
{
"name": "PHENYLEPHRINE HYDROCHLORIDE",
"strength": "5 mg/1"
}
],
"applicationNumber": "M012",
"marketingCategory": "OTC MONOGRAPH DRUG",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20180125",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "non-prescription",
"harmonizedIdentifiers": {
"nui": [
"N0000193956",
"N0000008867",
"N0000009560"
],
"upc": [
"0300450262530"
],
"unii": [
"362O9ITL9D",
"495W7451VQ",
"04JA59TNSJ"
],
"rxcui": [
"1243679"
],
"spl_set_id": [
"6c90b415-4c5f-49e5-beb6-4cf225797b21"
],
"pharm_class_pe": [
"Decreased Respiratory Secretion Viscosity [PE]",
"Increased Respiratory Secretions [PE]"
],
"pharm_class_epc": [
"Expectorant [EPC]"
],
"manufacturer_name": [
"Jones Healthcare Group - Packaging Services, Inc"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:67414-507_09759b68-4bd0-c41f-e063-6294a90a62a4"